OPKO Health Inc (OPK)
1.58
+0.02
(+1.28%)
USD |
NASDAQ |
Nov 22, 16:00
1.58
0.00 (0.00%)
After-Hours: 20:00
OPKO Health Revenue (Quarterly): 173.63M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 173.63M |
| June 30, 2024 | 182.19M |
| March 31, 2024 | 173.69M |
| December 31, 2023 | 181.90M |
| September 30, 2023 | 178.60M |
| June 30, 2023 | 265.42M |
| March 31, 2023 | 237.58M |
| December 31, 2022 | 185.34M |
| September 30, 2022 | 179.74M |
| June 30, 2022 | 309.89M |
| March 31, 2022 | 329.22M |
| December 31, 2021 | 401.33M |
| September 30, 2021 | 385.81M |
| June 30, 2021 | 442.41M |
| March 31, 2021 | 545.16M |
| December 31, 2020 | 494.67M |
| September 30, 2020 | 428.06M |
| June 30, 2020 | 301.21M |
| March 31, 2020 | 211.47M |
| December 31, 2019 | 224.34M |
| September 30, 2019 | 228.77M |
| June 30, 2019 | 226.37M |
| March 31, 2019 | 222.45M |
| December 31, 2018 | 221.85M |
| September 30, 2018 | 249.82M |
| Date | Value |
|---|---|
| June 30, 2018 | 263.68M |
| March 31, 2018 | 254.91M |
| December 31, 2017 | 160.98M |
| September 30, 2017 | 246.04M |
| June 30, 2017 | 292.60M |
| March 31, 2017 | 266.38M |
| December 31, 2016 | 171.32M |
| September 30, 2016 | 298.04M |
| June 30, 2016 | 357.10M |
| March 31, 2016 | 291.04M |
| December 31, 2015 | 276.19M |
| September 30, 2015 | 143.03M |
| June 30, 2015 | 42.43M |
| March 31, 2015 | 30.08M |
| December 31, 2014 | 25.53M |
| September 30, 2014 | 19.77M |
| June 30, 2014 | 23.54M |
| March 31, 2014 | 22.27M |
| December 31, 2013 | 20.69M |
| September 30, 2013 | 20.64M |
| June 30, 2013 | 23.82M |
| March 31, 2013 | 31.38M |
| December 31, 2012 | 16.26M |
| September 30, 2012 | 11.80M |
| June 30, 2012 | 10.21M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
173.63M
Minimum
Sep 2024
545.16M
Maximum
Mar 2021
291.58M
Average
251.50M
Median
Revenue (Quarterly) Benchmarks
| Innerscope Hearing Technologies Inc | 0.2508M |
| Boston Scientific Corp | 4.209B |
| ResMed Inc | 1.225B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 27.94M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.89M |
| Total Expenses (Quarterly) | 280.91M |
| EPS Diluted (Quarterly) | 0.03 |
| Enterprise Value | 1.098B |
| Gross Profit Margin (Quarterly) | 23.11% |
| Profit Margin (Quarterly) | 14.33% |
| Earnings Yield | -12.03% |
| Normalized Earnings Yield | -15.81 |